Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04435977
Title Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma (Immunocabo)
Acronym Immunocabo
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Clinico Humanitas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.